Protara Therapeutics Q3 EPS $-0.35
TARA•Protara Therapeutics reported third-quarter earnings per share of -$0.35, operating income of -$23.154 million, net income of -$21.688 million and operating expenses of $23.154 million.
1. Third-quarter results
Protara Therapeutics reported third-quarter earnings per share of -$0.35. Income from operations was -$23.154 million, net income was -$21.688 million and operating expenses were $23.154 million.
